Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study is a research paper published in Journal of Personalized Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
VA Merit Review
Grant: 1 I01 BX003856-01A1
VA Merit Review
Grant: 1 I01 BX004494-01
VA Merit Review
Grant: 1 R01 CA256973-01A1
VA Merit Review
Grant: T32CA121938
VA Merit Review
Grant: P30CA23100
NCI NIH HHS
Grant: R01 CA256973
NCI NIH HHS
Grant: CCSG Grant P30CA23100).
National Institutes of Health
Grant: 5T32CA121938-14
UCSD Cancer Center Training Program in Drug Development
National Institutes of Health
Grant: 3P30CA023100-25S4
Specialized Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA256973-02
Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer
FWCI
0.45
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals